blackarrowbio.tech

About blackarrowbio.tech

Black Arrow Biotech develops anti-cancer peptide (ACP) drugs by employing computational techniques to identify novel peptides that target cancer cells. The company focuses on addressing the complexities of cancer treatment through its expertise in pharmaceutical and biotech research.

Black Arrow Biotech develops anti-cancer peptide (ACP) drugs by employing computational techniques to identify novel peptides that target cancer cells. The company focuses on addressing the complexities of cancer treatment through its expertise in pharmaceutical and biotech research.

What does blackarrowbio.tech do?

Black Arrow Biotech develops anti-cancer peptide (ACP) drugs by employing computational techniques to identify novel peptides that target cancer cells. The company focuses on addressing the complexities of cancer treatment through its expertise in pharmaceutical and biotech research.

Where is blackarrowbio.tech located?

blackarrowbio.tech is based in Fort Worth, United States.

When was blackarrowbio.tech founded?

blackarrowbio.tech was founded in 2024.

Location
Fort Worth, United States
Founded
2024
Employees
5 employees
BT

blackarrowbio.tech

Black Arrow Biotech develops anti-cancer peptide (ACP) drugs by employing computational techniques to identify novel peptides that target cancer cells. The company focuses on addressing the complexities of cancer treatment through its expertise in pharmaceutical and biotech research.

Fort Worth, United StatesFounded 2024510+ followers3/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • Black Arrow Biotech develops anti-cancer peptide (ACP) drugs by employing computational techniques to identify novel peptides that target cancer cells. The company focuses on addressing the complexities of cancer treatment through its expertise in pharmaceutical and biotech research.
This profile is AI-generated and may contain inaccuracies.